Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
517 Leser
Artikel bewerten:
(2)

Cell Culture Vessels Market worth $8.03 billion by 2030 | MarketsandMarkets

DELRAY BEACH, Fla., Jan. 5, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Cell Culture Vessels Market is projected to grow from about USD 5.10 billion in 2025 to USD 8.03 billion by 2030, at a CAGR of 9.5%.

MarketsandMarkets Logo (PRNewsfoto/MarketsandMarkets)

Browse 600 market data Tables and 45 Figures spread through 650 Pages and in-depth TOC on "Cell Culture Vessels Market - Global Forecast to 2030"

Cell Culture Vessels Market Size & Forecast:

  • Market Size Available for Years: 2024-2030
  • 2025 Market Size: USD 5.10 billion
  • 2030 Projected Market Size: USD 8.03 billion
  • CAGR (2025-2030): 9.5%

Cell Culture Vessels Market Trends & Insights:

  • By product, the cell culture vessels market cell factory systems/cell stacks (vessel type) segment is expected to dominate the market in 2024.
  • By application, the biopharmaceutical production segment is projected to grow at the fastest rate from 2025 to 2030.
  • By end user, the pharmaceutical & biotechnology companies' segment is projected to grow at the fastest rate from 2025 to 2030.
  • The North America cell culture vessels market accounted for a 39.6% revenue share in 2024.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75000041

The cell culture vessels market is growing rapidly, driven by advancements in biologics, vaccines, and cell and gene therapies, which require efficient and scalable cell expansion platforms. The use of advanced cell culture methods for drug discovery and toxicity testing is therefore increasing demand among research institutes and CROs. Moreover, the shift toward high-density, scalable culture systems, along with increased investments in life sciences R&D, continues to encourage market growth. The growing shift toward more standardized and contamination-controlled vessels is therefore resulting in faster adoption rate.

Key players are focusing on product innovation in scalable, high-surface-area, single-use cell culture vessels to support biopharmaceutical manufacturing. They are also expanding global manufacturing capacity and distribution networks and strengthening collaborations with biopharma companies and CDMOs to ensure long-term adoption.

By product, the flasks segment is expected to register the fastest growth during the forecast period of 2025 to 2030.

the cell culture vessels market is divided into vessels and accessories. The vessels market is further divided into cell factory systems/cell stacks, roller/roux bottles, flasks, multiwell plates, and Petri dishes. Cell culture flasks are the fastest-growing product segment, driven by their widespread use in routine laboratory work and early-stage research. Their ease of handling, flexibility across multiple cell types, and suitability for small- to mid-scale experiments make them a preferred choice in both academic and industrial settings.

Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=75000041

By end user, the pharmaceutical & biotechnology companies segment is expected to be the largest segment in the cell culture vessels market.

the market for cell culture vessels has been segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies segment accounts for the largest share of the market in 2024 and is also the fastest-growing end user segment. This dominance is supported by the rise of biologics pipelines, increasing in-house research activity, and the growing need for consistent cell culture systems across discovery, development, and manufacturing workflows.

Asia Pacific is likely to be the fastest growing region in the global cell culture vessels market during the forecast period.

the global cell culture vessels market is divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the fastest-growing region, driven by the rapid expansion of biotech ecosystems, increased research funding, and rising biopharmaceutical production capacity. The region's growing focus on local drug development, coupled with improving laboratory infrastructure and cost advantages, continues to drive demand for cell culture vessels.

Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=75000041

Top Companies in Cell Culture Vessels Market:

The Top Companies in Cell Culture Vessels Market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge (Sweden), among others.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Related Reports:

Cell Culture Market - Global Forecast to 2030

3D Cell Culture Market - Global Forecast to 2030

Cell Based Assays Market - Global Forecast to 2030

Cell Expansion Market - Global Forecast to 2029

Cell Isolation Market - Global Forecast to 2029

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo - https://mma.prnewswire.com/media/1868219/5701227/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cell-culture-vessels-market-worth-8-03-billion-by-2030--marketsandmarkets-302652494.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.